Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes.

Autor: Hybel TE; Department of Hematology, Aarhus University Hospital.; Department of Clinical Medicine, Aarhus University., Sørensen EF; Department of Hematology, Aarhus University Hospital., Enemark MH; Department of Hematology, Aarhus University Hospital.; Department of Clinical Medicine, Aarhus University., Hemmingsen JK; Department of Hematology, Aarhus University Hospital., Simonsen AT; Department of Pathology, Aarhus University Hospital, Aarhus., Lauridsen KL; Department of Pathology, Aarhus University Hospital, Aarhus., Møller MB; Department of Pathology., Pedersen C; Department of Infectious Diseases, Odense University Hospital, Odense., Pedersen G; Department of Infectious Diseases, Aalborg University Hospital, Aalborg., Obel N; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen., Larsen CS; Department of Infectious Diseases., d'Amore F; Department of Hematology, Aarhus University Hospital., Hamilton-Dutoit S; Department of Pathology, Aarhus University Hospital, Aarhus., Stougaard M; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark., Vase MØ; Department of Hematology, Aarhus University Hospital., Ludvigsen M; Department of Hematology, Aarhus University Hospital.; Department of Clinical Medicine, Aarhus University.

Publikováno v: AIDS (London, England) [AIDS] 2024 Nov 15; Vol. 38 (14), pp. 1897-1906. Date of Electronic Publication: 2024 Aug 22.

Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort.

Autor: Enemark MH; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark. mariem@rm.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. mariem@rm.dk., Hemmingsen JK; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Andersen MD; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Hybel TE; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Bjørn ME; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., Josefsson PL; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., Pedersen LM; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Juul MB; Department of Hematology, Odense University Hospital, Odense, Denmark., Pedersen RS; Department of Hematology, Region Hospital Gødstrup, Gødstrup, Denmark., Thorsgaard M; Department of Hematology, Lillebælt Hospital, Vejle, Denmark., Sillesen IB; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Plesner TL; Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark., Hamilton-Dutoit SJ; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Jensen P; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Madsen C; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Ludvigsen M; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark. majlud@rm.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. majlud@rm.dk.

Publikováno v: Blood cancer journal [Blood Cancer J] 2024 Sep 30; Vol. 14 (1), pp. 167. Date of Electronic Publication: 2024 Sep 30.